Thus, to our knowledge, palmitoyl-L-carnitine may worsen tau pathology through direct metabolic effects and inflammation-mediated kinase activation, highlighting its multifaceted role in neuroinflammation, oxidative stress, and kinase dysregulation associated with AD. Here, MAPT is linked to Alzheimer disease.